Applying genomics in acute myeloid leukaemia

Published on

At the 20th Congress of the European Hematology Association (EHA), Prof Charles Craddock, Director of the Blood and Marrow Transplant Unit at the Queen Elizabeth Hospital, Birmingham and Professor of Haemato-oncology at the University of Birmingham, Birmingham, UK, explains how an improved understanding of genomics is changing the way acute myeloid leukaemia is being managed in the clinic.

View more programs featuring

Page last updated on January 26, 2016